Genetic alterations in the m6A demethyltransferase FTO gene were shown to be associated with ALL and AML risk, and there is evidence that indicates dysregulation of m6A methyltransferase METTL3 in AML (18, 19). Here, METTL3 is linked to acute lymphoblastic leukemia.